These findings suggest that the formation of immune complexes at the vaccination site between HIV or influenza vaccines and anti-Gal, results in a much more effective uptake, processing and presentation of the immunogenic peptides within the vaccine than with similar vaccines that lack α-gal epitopes. This evidence concerns the gene GAL and influenza.